MedTrace Logo

Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation

NCT00502554 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-07-26

No results posted yet for this study

Summary

Investigation of photopheresis as new therapy regimen in patients with bronchiolitis obliterans syndrome after lung transplantation in a controlled, randomized study

Conditions

  • Bronchiolitis Obliterans

Interventions

PROCEDURE

photopheresis

2-day cycles of photopheresis every 3 weeks for 3 months

Sponsors & Collaborators

  • Therakos

    collaborator INDUSTRY

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Fuehner Thomas, Doctor · Department Pneumology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00502554 on ClinicalTrials.gov